Vaxcyte, Inc. (PCVX) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -280.63M | -224.83M | -143.31M | -121.17M | -166.27M | -111.4M | -60.71M | -121.39M | -159.12M | -128.81M | -57.55M | -62.74M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -68.77% | -101.82% | -136.06% | 0.19% | -4.49% | 13.52% | -5.49% | -93.48% | -233.66% | -97.5% | -49.29% | -60.36% |
| Net Income | -320.62M | -246.51M | -212.83M | -166.57M | -140.72M | -137.08M | -103.12M | -128.7M | -95.02M | -180.8M | -92.66M | -68.34M |
| Depreciation & Amortization | 5.85M | 9.8M | 5.2M | 4.99M | 4.87M | 4.79M | 4.49M | 3.48M | 3.09M | 2.95M | 2.48M | 2.4M |
| Stock-Based Compensation | 0 | 36M | 35.31M | 36.93M | 30.61M | 24.37M | 21.27M | 21.56M | 17.63M | 13.35M | 13.22M | 12.54M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 37.05M | -27.78M | -3.05M | -30.2M | -11.53M | -991K | -12.56M | -9.93M | -10.99M | -2.37M | -14.57M | -11.84M |
| Working Capital Changes | -2.91M | 3.65M | 32.08M | 33.69M | -49.52M | -2.48M | 29.22M | -7.79M | -73.83M | 38.06M | 33.99M | 2.5M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -269K | 21.67M | 17.88M | 9.53M | -29.16M | 31.31M | 8.31M | -10.71M | 5.67M | 6.48M | 694K | 2.26M |
| Cash from Investing | -233.41M | 115.13M | 121.17M | 77.74M | 123.32M | -557.17M | -917.02M | -80.41M | -451.07M | -13.93M | 22.28M | -333.56M |
| Capital Expenditures | -14.79M | 5.57M | -12.05M | 19.52M | -26.75M | -30.03M | -38.08M | -45.37M | -12.07M | -57.07M | -7.34M | 2.14M |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -29.62K | 335.7K |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | -13.99M | 0 | -29.27M | 0 | 0 | 0 | 6.39M | 0 | 0 | 29.62K | -335.7K |
| Cash from Financing | 601.58M | 2.41M | -3.67M | 2.52M | 759K | 4.91M | 1.52B | 110.37M | 818.2M | 2.73M | 48.55M | 546.97M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 610.88M | -3.54M | 306K | 3.23M | 0 | 8K | 1.51B | 106.53M | 816.48M | -23K | 49M | 545.28M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -9.29M | 5.95M | -3.98M | -717K | 759K | 4.9M | 2.4M | 3.83M | 1.72M | 2.76M | -450K | 1.69M |
| Net Change in Cash | 86.88M | -107.12M | -25.52M | -40.11M | -41.03M | -662.31M | 531.73M | -92.84M | 214.06M | -147.68M | 14.33M | 150.58M |
| Free Cash Flow | -295.42M | -219.26M | -155.35M | -101.65M | -193.03M | -141.43M | -98.79M | -166.77M | -171.2M | -185.88M | -64.89M | -60.6M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -53.05% | -55.04% | -57.26% | 39.05% | -12.75% | 23.91% | -52.25% | -175.19% | -221.2% | -180.07% | -64.73% | -51.26% |
| FCF per Share | -2.12 | -1.61 | -1.14 | -0.75 | -1.42 | -1.15 | -0.80 | -1.42 | -1.53 | -1.78 | -0.64 | -0.62 |
| FCF Conversion (FCF/Net Income) | 0.88x | 0.91x | 0.67x | 0.73x | 1.18x | 0.81x | 0.59x | 0.94x | 1.67x | 0.71x | 0.62x | 0.92x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |